Byotrol PLC State approval in US (5684N)
May 10 2018 - 1:00AM
UK Regulatory
TIDMBYOT
RNS Number : 5684N
Byotrol PLC
10 May 2018
10(th) May, 2018
Byotrol Plc
("Byotrol" or the "Company")
APPROVAL RECEIVED FROM ALL U.S. STATES
FOR LONG-LASTING ANTI-MICROBIAL PRODUCT
FIRST US ORDER RECEIVED FOR ONWARD SALE ON AMAZON.COM
Byotrol plc, the specialist anti-microbial technology company,
is pleased to announce that it has now completed the product
registration process in the US for its 24-hour germ-kill surface
sanitizer.
All 50 US states have now formally approved the product for
sale, following receipt of approval from the US Environmental
Protection Agency in June 2017.
The formulation has been under development at Byotrol for over 8
years and the Directors believe it offers unique performance
characteristics, such as '24 hour surface protection against
bacteria'. The Directors are not aware of any other EPA-approved
product for US consumers that offers similar claims.
With the approvals in place, Byotrol is now able to sell in US
retail, on-line and to institutional customers. We will be
marketing our products under the name "Byotrol24"and will keep
shareholders informed as we make further commercial progress.
We are also pleased to announce that we have already secured our
first order for Byotrol24, for sale via a professional re-seller on
Amazon.com. Whilst not yet meaningful in financial terms, this is a
very important first step for us, not least as we have now
completed the necessary registration processes for Amazon, the
world's largest online shopping destination.
David Traynor, Chief Executive of Byotrol plc comments:
"We are now, finally, ready to go in the US. We are very excited
to complete the various regulatory processes and can now move
confidently on to commercialisation.
The order from the Amazon re-seller, whilst very small, is a key
first step for us and we hope is the first in a series of positive
announcements as we grow in the US."
Enquiries:
01925 742 000
David Traynor - Chief Executive, Byotrol plc
finnCap Ltd 020 7220 0500 (Nominated Adviser & Broker)
Geoff Nash/James Thompson - Corporate Finance
The information communicated in this announcement contains
inside information for the purposes of Article 7 of the Market
Abuse Regulation (EU) No. 596/2014.
Notes to Editors:
Byotrol plc (BYOT.L), quoted on AIM, is a specialist developer
of residual antimicrobial technologies, identifying, developing,
formulating and commercialising cutting-edge antimicrobial
solutions.
Our patented suite of technologies deliver powerful
broad-spectrum efficacy with residual performance optimised against
commonly occurring and industry-specific pathogens
Founded in 2005, the Company has developed the technology that
creates easier, safer and cleaner lives
For more information, please go to www.byotrol.co.uk
This information is provided by RNS
The company news service from the London Stock Exchange
END
MSCUKVVRWUAVRAR
(END) Dow Jones Newswires
May 10, 2018 02:00 ET (06:00 GMT)
Byotrol (LSE:BYOT)
Historical Stock Chart
From Apr 2024 to May 2024
Byotrol (LSE:BYOT)
Historical Stock Chart
From May 2023 to May 2024